STAT June 8, 2023
Damian Garde and Meg Tirrell and Adam Feuerstein

Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer’s disease treatments? And should lawyers be allowed to use thesauruses?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain Merck’s lawsuit against the federal government and why the company believes drug pricing negotiation is “tantamount to extortion.” We also discuss the health effects of Canadian wildfires, the highlights of the year’s biggest cancer research conference, and what could be...

Today's Sponsors

Upfront Healthcare

Today's Sponsor


Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom
Preventative Drug Lists Led to More Affordable Asthma Medication
Lawsuits To Block Medicare Drug Price Negotiations Are Very Unpopular Among Voters
Avalyn’s New Twist on Older Lung Disease Drugs Attracts $175M for Clinical Trials
GLP-1 drugs are transforming diabetes, obesity and more. Could a Nobel be next?

Share This Article